Glipizide: Clinical Trials

3 trials of Glipizide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Active not recruiting 1

Follow Glipizide: new trials by email Literature Review of Glipizide trials Research Report on Glipizide

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer
Glipizide - Pancreatic Cancer, Pancreatic Carcinoma
Phase 2Active not recruitingMemorial Sloan Kettering Cancer Center292023-12-052026-08-06
To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies
Canakinumab 150 mg, Placebo to Canakinumab - Type 2 Diabetes Mellitus, Impaired Glucose Tolerance
Phase 2CompletedNovartis2462010-02-012011-09-05
Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients
AZD1656, Placebo, Glipizide - Type II Diabetes Mellitus
Phase 2CompletedAstraZeneca5302009-10-012012-11-26

Conditions studied

Diabetes Mellitus, Type 2 (2)  ·  Glucose Intolerance (1)  ·  Metabolic Syndrome (1)  ·  Pancreatic Neoplasms (1)

Sponsors

AstraZeneca (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  Novartis (1)

Countries

Germany (2)  ·  United States (2)  ·  Australia (1)  ·  Canada (1)  ·  Chile (1)  ·  Finland (1)  ·  Hungary (1)  ·  India (1)  ·  Italy (1)  ·  Latvia (1)  ·  Lithuania (1)  ·  Mexico (1)  ·  Peru (1)  ·  Poland (1)  ·  Romania (1)

Top investigators

Azeez Farooki, MD (1)  ·  Eva Johnsson (1)  ·  John Wilding, DM FRCP (1)